Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 29. October 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9128  Previews Next
   
   Articles 1 - 20 / 182551  
   
Opposing roles of acid phosphatase 1 (ACP1) and ACP3 in prostate cancer progression.
BJU Int
Faria AVS, Ferreira-Halder CV, Peppelenbosch MP, Fuhler GM.
PMID: 42952235 [PubMed - as supplied by publisher]


Identification of ageing-related genes in prostate cancer with type 2 Diabetes using machine learning: a multi-omics study focusing on SOX4, PRNP, and FOXO4.
Artif Cells Nanomed Biotechnol
Zhang W, Zhang X, Zhang C, Shi X, Deng Y, Gao Y, Bi K, Wang Z, Chen G, Ye Z, An Z, Fu W.
PMID: 42952172 [PubMed - indexed for MEDLINE]


Combined Application of 3D Reconstruction and ICG Fluorescence Imaging in Pelvic Lymph Node Dissection for Bladder Cancer: A Retrospective Study.
J Endourol
Wei Y, Liu Q, Li S, Jia F, Li J, Hao H, Pang J, Li J, Yan P, Xing Q, Zhang H, He J, Liu C, Yang X.
PMID: 42952089 [PubMed - as supplied by publisher]


PSMA Theranostics for Prostate Cancer: Evidence, Pitfalls, and Implementation in Japan.
Int J Urol
Hirata K, Watanabe S, Wakabayashi H, Kudo K, Nishie A.
PMID: 42952025 [PubMed - indexed for MEDLINE]


PSMA-directed radioligand therapy and radium-223 in prostate cancer bone metastases.
Semin Nucl Med
Sathekge M.
PMID: 42951717 [PubMed - as supplied by publisher]


Talazoparib plus enzalutamide versus placebo plus enzalutamide in metastatic androgen pathway modulator-resistant (castration-resistant) prostate cancer (TALAPRO-2): a biomarker analysis of circulating tumour DNA and cells for prognosis and molecular profiling.
Lancet Oncol
Yip SM, Laird AD, Agarwal N, Zschäbitz S, Fizazi K, Matsubara N, Joung JY, Karsh LI, Carles J, Fay AP, Piulats JM, Fong PCC, Liu G, Albacker LA, Pasquina LW, Chelliserry J, Healy CG, Lin X, Kalac M, Azad AA.
PMID: 42950862 [PubMed - as supplied by publisher]


Intraductal and Cribriform Carcinoma of the Prostate: A Clinical Companion to the GUPS/ISUP Consensus Guidelines.
J Urol
Weiner AB, Shah RB, Paner GP, Ehdaie B, Eggener SE.
PMID: 42949829 [PubMed - as supplied by publisher]


Machine learning-based classification of renal cell carcinoma and upper tract urothelial carcinoma using preoperative hematological markers.
Biomed Rep
Nuwatkrisin K, Panwoon C, Senchan K, Sangkhamanon S, Seubwai W.
PMID: 42948584 [PubMed]


Combined Transarterial Embolization and Percutaneous CT-Guided Cryoablation of Renal Cell Carcinoma: A Retrospective Single-Center Study.
Cureus
Vogl TJ, Recoschewitz C, Cojocaru R, Nica AI, Adwan H.
PMID: 42948124 [PubMed]


Erdi Bazhen decoction for cancer-related fatigue due to qi and blood deficiency in prostate cancer patients receiving androgen deprivation therapy: an exploratory randomized, double-blind, placebo-controlled pilot clinical trial protocol.
Front Med (Lausanne)
Wei J, Ma J, Ma Z, Liu Y, Xu L, Mei X, Zhang P.
PMID: 42947754 [PubMed]


Predictors of guideline-concordant treatment intensification in metastatic castration-sensitive prostate cancer: an explainable machine learning study.
Front Oncol
Barton Odro E, Bychinski J, Van Alstyne T, Corsini C, Owen P, Jones CP, Krebs N, Solomon B, Vaca R, Williams C, Elsey R, Meissner T.
PMID: 42947672 [PubMed]


Light Microscopy-Based Techniques to Identify TFEB-Altered Renal Cell Carcinoma: A Comparison Study With TFE3-Rearranged Renal Cell Carcinoma and Common Renal Cell Tumors.
Am J Surg Pathol
Caliņ A, Marletta S, Giacometti C, Pedron S, Bariani E, Brunelli M, Antonini P, Stefanizzi L, Marcolini L, Martignoni G.
PMID: 42947507 [PubMed - as supplied by publisher]


ASO Author Reflections: (68)Ga-PSMA-11 PET/CT for Renal Cell Carcinoma Tumor Thrombus: Diagnostic Advances and Therapeutic Stratification.
Ann Surg Oncol
Lin BH, Zeng CL, Wu XH, Gao RC, Qiu QR, Chen YH, Xue XY, Zheng QS, Chen SH, Wei Y, Xu N.
PMID: 42946930 [PubMed - as supplied by publisher]


Focal therapy vs radical prostatectomy for localized prostate cancer: a systematic review, meta-analysis, bayesian network, and trial sequential analysis.
Int Urol Nephrol
Hinojosa-Gonzalez DE, Slawin B, Torres-Martinez M, Coady PJ, Hernandez BS, Calvillo-Ramirez A, Saffati G, Oppenheimer AG, de Jesus Aguirre-Vera G, Jones JA, Slawin JR.
PMID: 42946901 [PubMed - as supplied by publisher]


Prostate cancer worldwide: updated epidemiology, disparities, and screening implications.
Prostate Cancer Prostatic Dis
Bernardino RM, Nguyen DD, Carlsson SV, Gandaglia G, Schwen Z, Soputro NA, Watfa M, Al-Bayati A, El Hussein M, Campbell R, Daher K, Younis S, Nguyen J, Weight C, La Vecchia C, Zlotta AR, de Nunzio C, Abdollah F, Shoag JE, Basourakos S, Ferronha F, Cosenza A, Wallis C, Trinh QD, Fleshner N, Kaouk J, Autorino R.
PMID: 42946767 [PubMed - as supplied by publisher]


Overall Survival After Neoadjuvant Versus Adjuvant Chemotherapy for Invasive Urothelial Carcinoma of the Bladder: A Real-world Multicenter Cohort Study.
Anticancer Res
Chen HW, Li JR, Wang SS, Yang CK, Hsu JY, Chang CC.
PMID: 42946419 [PubMed - indexed for MEDLINE]


Circulating and Soluble Biomarkers for Predicting Inguinal Lymph Node Metastasis in Penile Squamous Cell Carcinoma: A Scoping Review.
Anticancer Res
Dell'atti L, Slyusar V.
PMID: 42946409 [PubMed - indexed for MEDLINE]


Global patterns and trends in testicular cancer incidence and mortality: A population-based ecological study.
Urology
Leng Q, Wu X, Xiong B, Wang Y, Gao Y, Zhang G, Li L, Hu X, Yi H.
PMID: 42946220 [PubMed - as supplied by publisher]


Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO Clinical Practice Guideline.
Pract Radiat Oncol
Morgan SC, Halthore A, Jia AY, Kishan AU, Loblaw A, Shen X, Tree A, DeMarco J, Dess RT, Eastwick G, Ellis R, Feldman AS, Kelly WK, Morrow E, Ost P, Wang EC, Washington SL 3rd, Weg ES, Bradfield L, Hoffman K.
PMID: 42946126 [PubMed - as supplied by publisher]


Pazopanib alternating with bevacizumab in patients with metastatic clear-cell renal cell carcinoma naive to treatment: a multicentre, single-arm, phase 1/2 trial.
Lancet Oncol
George S, Vaishampayan U, Hutson A, Groman A, Pili R, Green K, Herbst L, Kallicharan-Smith R, DiRaddo AM, Farrell E, Gopalakrishnan D, Heath E, Wulff E, Kilari D, Appleman L, Parikh R.
PMID: 42945979 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 182551    Page 1 of 9128  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1